Fox Chase Cancer Center Welcomes Dr. Simon Sung

Dr Sung
Fox Chase Cancer Center is pleased to announce the hiring of Simon Sung, MD, as an Associate Professor in the Department of Pathology.

PHILADELPHIA (April 4, 2024) — Fox Chase Cancer Center is pleased to announce the hiring of Simon Sung, MD, as an Associate Professor in the Department of Pathology.

Prior to coming to Fox Chase, Sung was an assistant professor in the Department of Pathology and Cell Biology at Columbia University Irving Medical Center in New York from August 2022 through February 2024 and from July 2018 through October 2020. He was also an assistant professor and associate director of the Cytology Fellowship Program in the Department of Pathology at Montefiore Medical Center, the university hospital for the Albert Einstein College of Medicine in Bronx, New York.

Sung earned his undergraduate degree from the Peabody Institute of the Johns Hopkins University and his medical degree from Columbia University Vagelos College of Physicians and Surgeons.

He completed an anatomic pathology residency at Columbia University Medical Center - New York Presbyterian Hospital and a fellowship in cytopathology at Weill Cornell Medical College - New York Presbyterian Hospital. He also completed a fellowship in general surgical pathology at Columbia University Medical Center.

Sung has authored over 20 peer-reviewed articles in such journals as Cancer Cytopathology, Diagnostic Cytopathology, the European Journal of Neuroscience, and the American Journal of Neuroradiology. He was awarded the National Institutes of Health Summer Research Grant in 2010, the Sigmund L. Wilens Prize for Excellence in Pathology in 2013, and the Intersociety Council for Pathology Information Trainee Travel Award in 2016.

He is currently a member of the United States and Canadian Academy of Pathology, the American Society of Cytopathology, the American Society for Clinical Pathology, and the College of American Pathologists.

Fox Chase Cancer Center (Fox Chase), which includes the Institute for Cancer Research and the American Oncologic Hospital and is a part of Temple Health, is one of the leading comprehensive cancer centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase is also one of just 10 members of the Alliance of Dedicated Cancer Centers. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence six consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.

For more information, call 888-369-2427